• Gentamycin Sulfate in Resistance Research

  2026-09-08

  Gentamycin Sulfate converts ribosome-level perturbation into a practical phenotype for bacterial protein synthesis research and resistance profiling. This workflow connects gentamycin susceptibility with carbapenemase-gene detection, plasmid localization, and transmission analysis in Gram-negative isolates.

• MTT: Mechanism, Evidence, and Assay Limits

  2026-09-08

  MTT is a tetrazolium-based colorimetric cell viability assay reagent that converts cellular reductive activity into a purple formazan signal. Its result is a metabolic proxy, so careful controls and orthogonal validation are required when interpreting proliferation, cytotoxicity, or viability.

• Moxifloxacin: Designing Mechanism-to-Phenotype Assays

  2026-09-07

  Moxifloxacin is more than a DNA gyrase inhibitor: it is a useful framework for connecting target engagement with bacterial, cellular, and systemic phenotypes. This article presents an assay-centered strategy for antibiotic toxicity research, formulation control, and interpretation of metabolic responses.

• X-press Tag Peptide for RHEB Purification

  2026-09-07

  X-press Tag Peptide combines affinity capture, Anti-Xpress antibody detection, and enterokinase-based tag removal in one N-terminal design. This guide translates those features into a practical workflow for recombinant RHEB studies, including experiments inspired by the UBE2F–SAG–RHEB–mTORC1 axis.

• Sulforaphane, Oxidative Stress, and NLRP3 in Colitis

  2026-09-05

  A 2024 study shows that Sulforaphane reduces oxidative stress and suppresses NLRP3 inflammasome-associated inflammation in DSS-induced mouse colitis. Its combination of in vivo disease modeling and RAW264.7 cell experiments supports a redox-sensitive mechanism, while also defining important limits for translation to human ulcerative colitis.

• ABT-263 Workflow for Mitochondrial Apoptosis

  2026-09-04

  Build a more informative ABT-263 and Navitoclax workflow by pairing apoptosis measurements with mitochondrial state, Bcl-2-family dependency, and resistance analysis. This practical guide covers reagent handling, dose-response design, pediatric acute lymphoblastic leukemia model considerations, and troubleshooting for reproducible cancer biology studies.

• Resazurin Cell Viability Assay Kit Guide

  2026-09-04

  Learn how the Resazurin Cell Viability Assay Kit can complement mechanistic bone research by separating treatment-related cytotoxicity from altered osteoblast metabolism. This guide translates recent PORCN-inhibition findings into practical, high-sensitivity cell viability assay decisions.

• Talabostat Mesylate: FAP Activity to Tumor Biology

  2026-09-03

  Talabostat mesylate, also known as PT-100, connects DPP4/FAP enzymology with tumor-microenvironment research. This article explains how to distinguish protease activity from protein abundance and how a FAP-sensitive nanoparticle study can improve assay design and interpretation.

• Recombinant Mouse IFN-γ in MASH-HCC Assays

  2026-09-03

  Recombinant Mouse IFN-γ provides a controlled cytokine perturbation for testing antigen-presentation competence in MASH-HCC models. This guide explains how Interferon gamma exposure can distinguish reversible metabolic suppression from persistent defects in tumor-cell immune signaling.

• Fasudil (HA-1077) HCl for Reliable Cell Assays

  2026-09-02

  Learn how Fasudil (HA-1077) HCl, SKU A5734, can support reproducible cell viability, proliferation, migration, and apoptosis workflows through defined ROCK inhibition. This scenario-driven guide covers assay design, stock preparation, interpretation, and practical vendor-selection criteria.

• Irinotecan Workflows in Colorectal Cancer Research

  2026-09-02

  Build more informative CPT-11 experiments by connecting prodrug activation with time-resolved DNA damage, apoptosis, and viability measurements. This practical guide covers soluble stock preparation, colorectal cancer cell line inhibition, xenograft translation, and troubleshooting model-dependent responses.

• NSC-23766 Rac GTPase Inhibitor Workflow

  2026-09-01

  NSC-23766 trihydrochloride provides a practical way to interrogate Rac1-dependent actin remodeling, apoptosis, endothelial barrier disruption, and tumor-cell behavior. This workflow connects dose-response experiments with live-cell phagocytosis assays to distinguish Rac1 activation from upstream Vav or Syk signaling.

• AICAR: AMPK Activation for Metabolic Research

  2026-09-01

  AICAR is a cell-permeable AMPK activator used to study energy metabolism regulation, inflammatory signaling, and cellular stress responses. Its research value is strongest when concentration, exposure time, solvent, and AMPK-specific controls are defined rather than treated as universal treatment parameters.

• E-64d: Cell-Permeable Calpain Inhibitor

  2026-08-31

  E-64d is a membrane-permeable, irreversible cysteine protease inhibitor used to study calpain, cathepsins, apoptosis, platelet activation, and seizure-related neuroprotection. Its reported calpain IC50 is approximately 0.5–1 μM, but assay conditions and target selectivity must be validated in each experimental system.

• ALDH2 Inhibition in APC-Deficient Colorectal Cancer

  2026-08-31

  The reference study identifies ALDH2 inhibition as a synthetic-lethal vulnerability in APC-deficient colorectal cancer and links this effect to ROS accumulation, ASK1/JNK activation, and apoptosis. Its combination of computational screening, cell-based validation, and xenograft experiments provides a mechanistic framework for genotype-directed cancer research while highlighting important limits on transferring Disulfiram activity across tumor models.

8572 records 1/572 page Next 12345 下5页 Last page